Clinical Trials Browser

Phase 2 × GV1001 peptide × Clear all

NCT00444782 2008-12-18

A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma.

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular